Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

10.1542/peds.102.3.531 ◽

1998 ◽

Vol 102 (3) ◽

pp. 531-537 ◽

Cited By ~ 1251

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Faculty Opinions recommendation of Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12105956.13254054 ◽

2011 ◽

Author(s):

Patrick C Wilson

Keyword(s):

Monoclonal Antibody ◽

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion

The Pediatric Infectious Disease Journal ◽

10.1097/00006454-199903000-00004 ◽

1999 ◽

Vol 18 (3) ◽

pp. 223-231 ◽

Author(s):

H. CODY MEISSNER ◽

ROBERT C. WELLIVER ◽

STEPHAN A. CHARTRAND ◽

BARBARA J. LAW ◽

LEONARD E. WEISMAN ◽

...

Keyword(s):

Monoclonal Antibody ◽

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Consensus Opinion ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort

Archives of Disease in Childhood ◽

10.1136/adc.83.4.313 ◽

2000 ◽

Vol 83 (4) ◽

pp. 313-316 ◽

Author(s):

S. J Clark

Keyword(s):

United Kingdom ◽

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Potential Impact ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Editorial - Respiratory Syncytial Virus Infection in High-Risk Infants

The Open Microbiology Journal ◽

10.2174/1874285801105010127 ◽

2011 ◽

Vol 5 (1) ◽

pp. 127-127

Author(s):

Bernhard Resch

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high-risk infants in Japan

Pediatrics International ◽

10.1111/j.1442-200x.2010.03249.x ◽

2011 ◽

Vol 53 (3) ◽

pp. 368-373 ◽

Author(s):

Satoshi Kusuda ◽

Naoto Takahashi ◽

Takami Saitoh ◽

Masaru Terai ◽

Hisashi Kaneda ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Pediatric Ward ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children

The Journal of Immunology ◽

10.4049/jimmunol.179.5.3171 ◽

2007 ◽

Vol 179 (5) ◽

pp. 3171-3177 ◽

Author(s):

Agnes A. Awomoyi ◽

Prasad Rallabhandi ◽

Toni I. Pollin ◽

Eva Lorenz ◽

Marcelo B. Sztein ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Young Children ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants ◽

Infants And Young Children

Download Full-text

PIN35 COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS INFECTION IN HIGH-RISK INFANTS IN JAPAN

Value in Health ◽

10.1016/s1098-3015(10)69055-9 ◽

2007 ◽

Vol 10 (3) ◽

pp. A170 ◽

Author(s):

S Ikeda ◽

M Kobayashi

Keyword(s):

Respiratory Syncytial Virus ◽

Cost Effectiveness ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Clinical and Pharmacological Aspects of Immunoprophylaxis for Respiratory Syncytial Virus Infection in High-Risk Infants

Current Drug Metabolism ◽

10.2174/1389200211314020010 ◽

2013 ◽

Vol 14 (2) ◽

pp. 216-225

Author(s):

Marcello Lanari ◽

Michela Silvestri ◽

Giovanni A. Rossi

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants

Journal of Paediatrics and Child Health ◽

10.1046/j.1440-1754.2002.00057.x ◽

2002 ◽

Vol 38 (6) ◽

pp. 550-554 ◽

Author(s):

AM Vogel ◽

DR Lennon ◽

R Broadbent ◽

CA Byrnes ◽

K Grimwood ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis

Archives of Disease in Childhood - Fetal and Neonatal Edition ◽

10.1136/adc.2003.029710 ◽

2005 ◽

Vol 90 (1) ◽

pp. F64-F68 ◽

Author(s):

T Heikkinen

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Hospital Admission ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text